HealthQuill Health
Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.
Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the drug’s identity, quality or safety.
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
The World Health Organization has added a second malaria vaccine to its list of prequalified vaccines to enable greater access to inoculate children as a primary preventive measure.
Drugs Health Pharma

WHO places second malaria jab on ‘list of prequalified vaccines’

HQ Team December 21, 2023: The World Health Organization has added a second malaria vaccine to its list of prequalified vaccines to enable.

Read More
The WHO, has included noma in its official list of neglected tropical diseases to expand health services to the world’s most vulnerable populations.
Drugs Health Pharma

Noma added to WHO’s list of 21 neglected tropical diseases 

HQ Team December 21, 2023: The WHO, has included noma in its official list of neglected tropical diseases to expand health services to.

Read More
The USFDA has approved Calliditas Therapeutics’ oral drug to treat loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) and at risk of disease progression.
Drugs Health Pharma

Sweden’s Calliditas gets FDA nod for oral drug to treat kidney loss function

HQ Team December 21, 2023: Sweden’s Calliditas Therapeutics has got the USFDA green light for its oral drug to treat loss of kidney.

Read More
The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most serious” type.
Drugs Health Pharma

Recall of Philips imaging devices ‘most serious’: USFDA says

HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most.

Read More
Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced.
Drugs Health Pharma

Alarming impact of antimicrobial resistance on mortality in Africa

HQ Team December 20, 2023: Researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine.

Read More
Patients who brush their teeth may be saving themselves from hospital-acquired pneumonia and other outcomes, according to a study by US researchers.
Drugs Health Pharma

Toothbrushing in ICU may save you from hospital-acquired pneumonia

HQ Team December 20, 2023: Patients who brush their teeth may be saving themselves from hospital-acquired pneumonia and other outcomes, according to a.

Read More
Covid-19 lung damage
Health Medical Pharma

Caution advised amid rise in Covid cases linked to JN.1 subvariant

HQ Team December 19, 2023: An increase in Covid-19 cases across the world is causing concern. The surge is attributed to the detection.

Read More
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.
Drugs Health Medical

Opinion: Sickle Cell Disease and gene therapy

By K. Leelamoni December 19, 2023: Recent reports about the FDA’s approval of gene therapy to treat Sickle Cell Anemia mark a major.

Read More